Boehringer Ingelheim — Vetmedin (pimobendan) Chewable Tablets (Rx) 2.5 mg, 50 ct
$78.00
103184
Please note that this item requires a veterinarian's prescription.
Convenient ways to do that are:
Convenient ways to do that are:
- Your veterinarian can contact us by fax/phone.
- Create an account or simply sign in if you have a prescription already on file.
Vaccine and Rx items are not returnable.
About This Product
SKU093066
EID 103184
BrandBoehringer Ingelheim
Vetmedin (Pimobendan) is in a class of heart treatments named ""inodilators"" used in the management of certain types of congestive heart failure in dogs. These medications increase the heart muscle's ability to pump blood. Vetmedin increases the ability of the heart muscle to contract and also open up the blood vessels taking blood to and away from the heart. This reduces the heart's workload as it pumps blood throughout the dog's body. Specifically used for the management of the signs of mild, moderate, or severe congestive heart failure in dogs. The safety of pimobendan has not been evaluated in dogs younger than 6 months of age.
Dosage:
VETMEDIN® (pimobendan) Chewable Tablets should be administered orally at a total daily dose of 0.23mg/lb (0.5 mg/kg) body weight.
- The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (ie, morning and evening)
- Any suitable combination of whole or half tablets may be used
- The tablets are scored and the calculated dosage should be provided to the nearest half-tablet increment
Contraindications:
VETMEDIN® (pimobendan) Chewable Tablets should not be given in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons.
Warnings:
Only for use in dogs with clinical evidence of heart failure. At 3 and 5 times the recommended dosage, administered over a 6-month period of time, pimobendan caused an exaggerated hemodynamic response in the normal dog heart, which was associated with cardiac pathology.
Human Warnings: Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans.
Precautions:
The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches.
Adverse Reactions:
The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia.
For more information, please see full prescribing information.
The unique mode of action of VETMEDIN® (pimobendan) Chewable Tablets acts as both a positive inotrope and potent, balanced vasodilator, simultaneously dilating veins and arteries. In this form, the chew enters the GI tract and is rapidly dissolved and absorbed.
- Proprietary formulation ensures optimal bioavailability that in turn ensures optimal therapeutic effect
- In a clinical study, the unique dual mode of action was shown to increase survival time and quality of life compared to ACE inhibitors.1,2
- Published evidence of improved clinical parameters and reduced heart size when compared to dogs on ACE inhibitors3
- Recommended by American College of Veterinary Internal Medicine (ACVIM) specialty of cardiology panel as part of first-line therapy in dogs diagnosed with heart failure to ensure optimal patient outcomes4
- Beef-flavored chewable tablet ensures high levels of acceptability that in turn promotes compliance10,11
- Meets FDA standards of product efficacy, stability, and strength